Publicly subsidised smoking cessation medicines in times of COVID-19 in Australia: An interrupted time series analysis.

Baliunas, Dolly; Gartner, Coral; Hollingworth, Samantha A; Sullivan, Clair; Comans, Tracy; Pole, Jason D

Baliunas, Dolly; Gartner, Coral; Hollingworth, Samantha A; Sullivan, Clair; Comans, Tracy; Pole, Jason D.

Afiliación

Baliunas D; School of Public Health, The University of Queensland, Brisbane, Australia.
Gartner C; Dalla Lana School of Public Health, The University of Toronto, Toronto, Canada.
Hollingworth SA; School of Public Health, The University of Queensland, Brisbane, Australia.
Sullivan C; School of Pharmacy, The University of Queensland, Brisbane, Australia.
Comans T; Centre for Health Services Research, The University of Queensland, Brisbane, Australia.
Pole JD; Metro North Hospital and Health Service, Royal Brisbane and Women's Hospital, Brisbane, Australia.

Drug Alcohol Rev ; 42(1): 225-232, 2023 01.

Article en En | MEDLINE | ID: mdl-36173196

Asunto(s)

COVID-19; Cese del Hábito de Fumar; Humanos; Vareniclina; Nicotina; Agonistas Nicotínicos; Análisis de Series de Tiempo Interrumpido; Bupropión; Fumar; Pandemias; Dispositivos para Dejar de Fumar Tabaco; Preparaciones Farmacéuticas

Palabras clave

COVID-19; nicotine replacement therapy; routinely collected health-care data; smoking cessation treatment; varenicline

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cese del Hábito de Fumar / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Drug Alcohol Rev Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google